Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker

Abstract

Detection of the networks involved in cancers has an important role in increasing our knowledge about them, but unfortunately most of these networks are unknown. Long non-coding RNAs (lncRNA) refer to larger than 200

Allicin affects immunoreactivity of osteosarcoma cells through lncRNA CBR3-AS1

“…As mentioned earlier, CBR3-AS1, as a newly discovered member of the lncRNA family, is located in the antisense region of CBR3 and was first identified for its aberrant expression in breast cancer [ 26 ]. With the deepening of research, the role of CBR3-AS1 in OS has attracted increasing attention [ 27 ], and the research on the action pathway of allicin also points to the possibility that CBR3-AS1 may be one of the key links [ 12 ].…”

LncRNA-CBR3-AS1 promotes and enhances the malignancy of ulcerative colitis via targeting miRNA-145-5p/FN1

“…LncRNA CASC11 was up-regulated in bladder cancer (11). A brand-new lncRNA called CBR3-AS1 has been found to promote breast cancer cell metastasis (12). Furthermore, through Wnt/beta-catenin signaling, Ln-cRNA CBR3-AS1 enhanced NSCLC (13).…”